Generally, CD47 is overexpressed on the surface of B-cell ALL cells and recognized as an inferior prognosis marker associated with worse outcomes in pediatric ALL patients, such as treatment failure and even death (122, 123). The gene discussed is CD47; the disease is acute lymphoblastic leukemia.